Iron overload reduces adiponectin receptor expression via a ROS/FOXO1‐dependent mechanism leading to adiponectin resistance in skeletal muscle cells
- 11 January 2021
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 236 (7) , 5339-5351
Abstract
Iron overload (IO) is a common yet underappreciated finding in metabolic syndrome (MetS) patients. With the prevalence of MetS continuing to rise, it is imperative to further elucidate cellular mechanisms leading to metabolic dysfunction. Adiponectin has many beneficial effects and is a therapeutic target for the treatment of MetS and cardiovascular diseases. IO positively correlates with reduced circulating adiponectin levels yet the impact of IO on adiponectin action is unknown. Here, we established a model of IO in L6 skeletal muscle cells and found that IO‐induced adiponectin resistance. This was shown via reduced p38 mitogen‐activated protein kinase phosphorylation in response to the small molecule adiponectin receptor (AdipoR) agonist, AdipoRon, in presence of IO. This correlated with reduced messenger RNA and protein levels of AdipoR1 and its facilitative signaling binding partner, APPL1. IO caused phosphorylation, nuclear extrusion, and thus inhibition of FOXO1, a known transcription factor regulating AdipoR1 expression. The antioxidant N‐acetyl cystine attenuated the production of reactive oxygen species (ROS) by IO, and blunted its effect on FOXO1 phosphorylation and removal from the nucleus, as well as subsequent adiponectin resistance. In conclusion, our study identifies a ROS/FOXO1/AdipoR1 axis as a cause of skeletal muscle adiponectin resistance in response to IO. This new knowledge provides insight into a cellular mechanism with potential relevance to disease pathophysiology in MetS patients with IO.Keywords
Funding Information
- Canadian Institutes of Health Research (Project grant to GS)
This publication has 53 references indexed in Scilit:
- Serum adiponectin/Ferritin ratio in relation to the risk of type 2 diabetes and insulin sensitivityDiabetes Research and Clinical Practice, 2018
- The Definition and Prevalence of Obesity and Metabolic Syndrome2017
- Mechanisms Linking Glucose Homeostasis and Iron Metabolism Toward the Onset and Progression of Type 2 DiabetesDiabetes Care, 2015
- Signaling mechanisms underlying the insulin-sensitizing effects of adiponectinBest Practice & Research Clinical Endocrinology & Metabolism, 2014
- Adiponectin Action: A Combination of Endocrine and Autocrine/Paracrine EffectsFrontiers in Endocrinology, 2011
- Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective studyDiabetologia, 2007
- Iron Stores, Blood Donation, and Insulin Sensitivity and SecretionClinical Chemistry, 2005
- Effect of Iron Depletion on Cardiovascular Risk FactorsAnnals of the New York Academy of Sciences, 2002
- Iron Biology in Immune Function, Muscle Metabolism and Neuronal FunctioningThe Journal of Nutrition, 2001
- Blood Donations and Risk of Coronary Heart Disease in MenCirculation, 2001